GONAPEPTYL 3.75 mg, powder and solvent for injectable suspension with extended release in pre-filled syringes syringe, 1 ml
Active ingredients: Triptorelin acetate, Triptorelin
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for injectable suspension with extended releasesyringe, 1 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GONAPEPTYL 3,75 mg, poudre et solvant pour suspension injectable à libération prolongée en seringues pré-remplies
- Pharmaceutical form
- poudre et solvant pour suspension injectable à libération prolongée
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre - 1 seringue(s) préremplie(s) en verre de 1 ml
- Marketing authorisation holder
- FERRING (FRANCE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Oct 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68628809CIP73584467CIP133400935844675Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIPTORÉLINEpoudre | 3.75 mg · une seringue pré-remplie | FT |
| ACÉTATE DE TRIPTORÉLINEpoudre | 4,12 mg · une seringue pré-remplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.